Influence of Age on the Disposition and Renal Handling of Enprofylline in Rats

ISAO MURAOKA, TAKAAKI HASEGAWA, MASAYUKI NADAI, LI WANG, OSAMU TAGAYA, Toshitaka Nabeshima

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Abstract— The effects of ageing on the pharmacokinetics, renal handling and protein binding of enprofylline were investigated in 6‐, 13‐ and 18‐month‐old male Fischer 344 rats. Concentrations of enprofylline in plasma and urine were determined by HPLC, and pharmacokinetic parameters were estimated by model‐independent methods. No significant differences in the volume of distribution, systemic clearance of enprofylline or urinary recovery of unchanged enprofylline (> 85%) were observed among any of the groups of rats. The dissociation constant and free fatty acid concentration in plasma increased with age. Age‐dependent decreases in the systemic clearance for unbound drug were observed, and the volume of distribution for unbound drug tended to decrease with age. The ratio of systemic clearance for unbound drug to the glomerular filtration rate (GFR) decreased with ageing. Ageing was associated with decreases in the apparent maximum capacity of transport (Vmax) (223·33,160·24 and 142·98 μg min−1 kg−1 for 6‐, 13‐ and 18‐month‐old rats, respectively) and in the tubular secretory intrinsic clearance (Vmax/Km) of enprofylline (75·45, 51·03 and 44·13 mL min−1 kg−1, respectively), while a slight change in the Michaelis‐Menten constant (Km) was observed. These results indicate that the mechanism responsible for age‐related changes in the disposition and renal handling of enprofylline may be responsible for a decrease in the ability of the tubular anion transport system. 1994 Royal Pharmaceutical Society of Great Britain

Original languageEnglish
Pages (from-to)230-234
Number of pages5
JournalJournal of Pharmacy and Pharmacology
Volume46
Issue number3
DOIs
Publication statusPublished - 01-01-1994
Externally publishedYes

Fingerprint

Kidney
Pharmacokinetics
Pharmaceutical Preparations
Inbred F344 Rats
Glomerular Filtration Rate
Nonesterified Fatty Acids
Protein Binding
Anions
enprofylline
High Pressure Liquid Chromatography
Urine

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

MURAOKA, ISAO ; HASEGAWA, TAKAAKI ; NADAI, MASAYUKI ; WANG, LI ; TAGAYA, OSAMU ; Nabeshima, Toshitaka. / Influence of Age on the Disposition and Renal Handling of Enprofylline in Rats. In: Journal of Pharmacy and Pharmacology. 1994 ; Vol. 46, No. 3. pp. 230-234.
@article{faa35b55c6d34de59e19d5fce6ffb74d,
title = "Influence of Age on the Disposition and Renal Handling of Enprofylline in Rats",
abstract = "Abstract— The effects of ageing on the pharmacokinetics, renal handling and protein binding of enprofylline were investigated in 6‐, 13‐ and 18‐month‐old male Fischer 344 rats. Concentrations of enprofylline in plasma and urine were determined by HPLC, and pharmacokinetic parameters were estimated by model‐independent methods. No significant differences in the volume of distribution, systemic clearance of enprofylline or urinary recovery of unchanged enprofylline (> 85{\%}) were observed among any of the groups of rats. The dissociation constant and free fatty acid concentration in plasma increased with age. Age‐dependent decreases in the systemic clearance for unbound drug were observed, and the volume of distribution for unbound drug tended to decrease with age. The ratio of systemic clearance for unbound drug to the glomerular filtration rate (GFR) decreased with ageing. Ageing was associated with decreases in the apparent maximum capacity of transport (Vmax) (223·33,160·24 and 142·98 μg min−1 kg−1 for 6‐, 13‐ and 18‐month‐old rats, respectively) and in the tubular secretory intrinsic clearance (Vmax/Km) of enprofylline (75·45, 51·03 and 44·13 mL min−1 kg−1, respectively), while a slight change in the Michaelis‐Menten constant (Km) was observed. These results indicate that the mechanism responsible for age‐related changes in the disposition and renal handling of enprofylline may be responsible for a decrease in the ability of the tubular anion transport system. 1994 Royal Pharmaceutical Society of Great Britain",
author = "ISAO MURAOKA and TAKAAKI HASEGAWA and MASAYUKI NADAI and LI WANG and OSAMU TAGAYA and Toshitaka Nabeshima",
year = "1994",
month = "1",
day = "1",
doi = "10.1111/j.2042-7158.1994.tb03785.x",
language = "English",
volume = "46",
pages = "230--234",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "3",

}

Influence of Age on the Disposition and Renal Handling of Enprofylline in Rats. / MURAOKA, ISAO; HASEGAWA, TAKAAKI; NADAI, MASAYUKI; WANG, LI; TAGAYA, OSAMU; Nabeshima, Toshitaka.

In: Journal of Pharmacy and Pharmacology, Vol. 46, No. 3, 01.01.1994, p. 230-234.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Influence of Age on the Disposition and Renal Handling of Enprofylline in Rats

AU - MURAOKA, ISAO

AU - HASEGAWA, TAKAAKI

AU - NADAI, MASAYUKI

AU - WANG, LI

AU - TAGAYA, OSAMU

AU - Nabeshima, Toshitaka

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Abstract— The effects of ageing on the pharmacokinetics, renal handling and protein binding of enprofylline were investigated in 6‐, 13‐ and 18‐month‐old male Fischer 344 rats. Concentrations of enprofylline in plasma and urine were determined by HPLC, and pharmacokinetic parameters were estimated by model‐independent methods. No significant differences in the volume of distribution, systemic clearance of enprofylline or urinary recovery of unchanged enprofylline (> 85%) were observed among any of the groups of rats. The dissociation constant and free fatty acid concentration in plasma increased with age. Age‐dependent decreases in the systemic clearance for unbound drug were observed, and the volume of distribution for unbound drug tended to decrease with age. The ratio of systemic clearance for unbound drug to the glomerular filtration rate (GFR) decreased with ageing. Ageing was associated with decreases in the apparent maximum capacity of transport (Vmax) (223·33,160·24 and 142·98 μg min−1 kg−1 for 6‐, 13‐ and 18‐month‐old rats, respectively) and in the tubular secretory intrinsic clearance (Vmax/Km) of enprofylline (75·45, 51·03 and 44·13 mL min−1 kg−1, respectively), while a slight change in the Michaelis‐Menten constant (Km) was observed. These results indicate that the mechanism responsible for age‐related changes in the disposition and renal handling of enprofylline may be responsible for a decrease in the ability of the tubular anion transport system. 1994 Royal Pharmaceutical Society of Great Britain

AB - Abstract— The effects of ageing on the pharmacokinetics, renal handling and protein binding of enprofylline were investigated in 6‐, 13‐ and 18‐month‐old male Fischer 344 rats. Concentrations of enprofylline in plasma and urine were determined by HPLC, and pharmacokinetic parameters were estimated by model‐independent methods. No significant differences in the volume of distribution, systemic clearance of enprofylline or urinary recovery of unchanged enprofylline (> 85%) were observed among any of the groups of rats. The dissociation constant and free fatty acid concentration in plasma increased with age. Age‐dependent decreases in the systemic clearance for unbound drug were observed, and the volume of distribution for unbound drug tended to decrease with age. The ratio of systemic clearance for unbound drug to the glomerular filtration rate (GFR) decreased with ageing. Ageing was associated with decreases in the apparent maximum capacity of transport (Vmax) (223·33,160·24 and 142·98 μg min−1 kg−1 for 6‐, 13‐ and 18‐month‐old rats, respectively) and in the tubular secretory intrinsic clearance (Vmax/Km) of enprofylline (75·45, 51·03 and 44·13 mL min−1 kg−1, respectively), while a slight change in the Michaelis‐Menten constant (Km) was observed. These results indicate that the mechanism responsible for age‐related changes in the disposition and renal handling of enprofylline may be responsible for a decrease in the ability of the tubular anion transport system. 1994 Royal Pharmaceutical Society of Great Britain

UR - http://www.scopus.com/inward/record.url?scp=0028214702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028214702&partnerID=8YFLogxK

U2 - 10.1111/j.2042-7158.1994.tb03785.x

DO - 10.1111/j.2042-7158.1994.tb03785.x

M3 - Article

VL - 46

SP - 230

EP - 234

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 3

ER -